Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

Clinical trial NCT04471038 · COMPLETED

Trial details

NCT number: NCT04471038
Sponsor: SAb Biotherapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Type A Influenza Type B Influenza

Start date: 2020-07-29
Primary completion: 2021-04-19
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.